AusBiotech conference Brisbane
1 – 3 Nov 2023
Oculus BioMed Limited partners with The Centre for Eye Research Australia (CERA) in a deal to develop “SwitchGene” – Eye Gene therapies. 11 Oct 2023
October 9, 2023Mr Roger McPherson appointed CFO / Company Secretary 27 Nov 2023
November 27, 2023
OBM recently attended Australias premier biotechnology conference in Brisbane – represented by CEO Andrew Coloretti & Non-Executive Director Michelle Gallaher. The conference included valuable one-on-one private meetings with industry executives and service providers. Importantly it was an opportunity to build brand awareness, network with delegates and exchange information about OBM.
